Skip to main content

Animations

MJFF Publications

1011 - 1020 of 6433 Results
Title
Year
  • Year
  • 2017
  • 2010
  • 2010
  • 2015
  • 2018
  • 2015
  • 2017
  • 2015
  • 2010
  • 2011
  • Summary Details
    OPEN
    Title: MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2017.00329
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.642
    Citation Count: 754
  • Summary Details
    OPEN
    Title: Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.536
    Best OA location URL: http://doi.org/10.1038/ng.536
    Citation Count: 567
  • Summary Details
    OPEN
    Title: M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2015.10.039
    Citation Count: 219
  • Summary Details
    OPEN
    Title: Model-based and Model-free Machine Learning Techniques for Diagnostic Prediction and Classification of Clinical Outcomes in Parkinson’s Disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-24783-4
    Citation Count: 173
  • Summary Details
    OPEN
    Title: Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embj.201591593
    Citation Count: 173
  • Summary Details
    OPEN
    Title: 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25060
    Citation Count: 164
  • Summary Details
    OPEN
    Title: Tau positron emission tomographic imaging in aging and early Alzheimer disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24546
    Citation Count: 878
  • Summary Details
    OPEN
    Title: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease Neuropathology
    Journal Name: Brain Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/j.1750-3639.2011.00557.x
    Citation Count: 146
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.